1. Home
  2. LAW vs PRTC Comparison

LAW vs PRTC Comparison

Compare LAW & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CS Disco Inc.

LAW

CS Disco Inc.

HOLD

Current Price

$7.76

Market Cap

466.2M

Sector

Technology

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$16.64

Market Cap

386.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAW
PRTC
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
466.2M
386.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
LAW
PRTC
Price
$7.76
$16.64
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$7.75
N/A
AVG Volume (30 Days)
204.1K
1.8K
Earning Date
02-19-2026
08-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
$152,677,000.00
$6,391,000.00
Revenue This Year
$8.51
N/A
Revenue Next Year
$8.39
N/A
P/E Ratio
N/A
$8.02
Revenue Growth
6.33
1265.60
52 Week Low
$3.31
$13.30
52 Week High
$9.11
$20.00

Technical Indicators

Market Signals
Indicator
LAW
PRTC
Relative Strength Index (RSI) 49.56 48.09
Support Level $7.73 $16.72
Resistance Level $8.33 $16.99
Average True Range (ATR) 0.27 0.40
MACD -0.13 0.02
Stochastic Oscillator 5.52 30.88

Price Performance

Historical Comparison
LAW
PRTC

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: